{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:08:38Z","timestamp":1786982918791,"version":"build-2736575974"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Monaghan Medical Corporation Inc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pulm Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s41030-026-00354-1","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:51:18Z","timestamp":1774680678000},"page":"485-533","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Oscillating Positive Expiratory Pressure (OPEP) Therapy in Bronchiectasis and Chronic Obstructive Pulmonary Disease (COPD): A Narrative Review of Clinical Studies"],"prefix":"10.1007","volume":"12","author":[{"given":"Judy L.","family":"Schloss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic P.","family":"Coppolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0026-7242","authenticated-orcid":false,"given":"Jason A.","family":"Suggett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breeanna R.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5811-236X","authenticated-orcid":false,"given":"Mark W.","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5456-8425","authenticated-orcid":false,"given":"Jolyon P.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"issue":"1","key":"354_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/ACI.0b013e3280114eef","volume":"7","author":"MB Antunes","year":"2007","unstructured":"Antunes MB, Cohen NA. Mucociliary clearance: a critical upper airway host defense mechanism and methods of assessment. Curr Opin Allergy Clin Immunol. 2007;7(1):5\u201310. https:\/\/doi.org\/10.1097\/ACI.0b013e3280114eef.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"354_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2023.107262","volume":"214","author":"M Cazzola","year":"2023","unstructured":"Cazzola M, Blasi F. There is still no established and accepted definition of COPD. Respir Med. 2023;214:107262. https:\/\/doi.org\/10.1016\/j.rmed.2023.107262.","journal-title":"Respir Med"},{"key":"354_CR3","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.2147\/COPD.S227377","volume":"14","author":"JU Lim","year":"2019","unstructured":"Lim JU, Kim EK, Lim SY, et al. Mixed phenotype of emphysema and airway wall thickening is associated with frequent exacerbation in chronic obstructive pulmonary disease patients. Int J Chron Obstruct Pulmon Dis. 2019;14:3035\u201342. https:\/\/doi.org\/10.2147\/COPD.S227377.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"354_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2045894018758528","volume":"8","author":"F Polverino","year":"2018","unstructured":"Polverino F, Celli BR, Owen CA. COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover Conference Series). Pulm Circ. 2018;8(1):1\u201318. https:\/\/doi.org\/10.1177\/2045894018758528.","journal-title":"Pulm Circ"},{"issue":"3","key":"354_CR5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.chest.2025.03.026","volume":"168","author":"X Li","year":"2025","unstructured":"Li X, Feng S, Yang Y, et al. Association between airway mucus plugs and risk of moderate-to-severe exacerbations in patients with COPD. Chest. 2025;168(3):627\u201338. https:\/\/doi.org\/10.1016\/j.chest.2025.03.026.","journal-title":"Chest"},{"key":"354_CR6","unstructured":"Global initiative for chronic obstructive lung diseases (GOLD) 2025 report. 2025. https:\/\/goldcopd.org\/2025-gold-report\/. Accessed Oct 8, 2025."},{"issue":"19","key":"354_CR7","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1056\/NEJMc2502456","volume":"392","author":"SK Mettler","year":"2025","unstructured":"Mettler SK, Nardelli P, Campo MI, et al. Longitudinal changes in airway mucus plugs and FEV1 in COPD. N Engl J Med. 2025;392(19):1973\u20135. https:\/\/doi.org\/10.1056\/NEJMc2502456.","journal-title":"N Engl J Med"},{"key":"354_CR8","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1183\/09031936.00172007","volume":"32","author":"PR Burgel","year":"2008","unstructured":"Burgel PR, Nadel JA. Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases. Eur Respir J. 2008;32:1068\u201381. https:\/\/doi.org\/10.1183\/09031936.00172007.","journal-title":"Eur Respir J"},{"key":"354_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1165\/rcmb.2006-0082SF","volume":"35","author":"SH Randell","year":"2006","unstructured":"Randell SH, Boucher RC. Effective mucus clearance is essential for respiratory health. Am J Respir Cell Mol Biol. 2006;35:20\u20138. https:\/\/doi.org\/10.1165\/rcmb.2006-0082SF.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"354_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1183\/09059180.00004410","volume":"19","author":"PR Burgel","year":"2010","unstructured":"Burgel PR, Martin C. Mucus hypersecretion in COPD: should we only rely on symptoms? Eur Respir Rev. 2010;19:94\u20136. https:\/\/doi.org\/10.1183\/09059180.00004410.","journal-title":"Eur Respir Rev"},{"issue":"23","key":"354_CR11","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1056\/NEJMra0910061","volume":"363","author":"JV Fahy","year":"2010","unstructured":"Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med. 2010;363(23):2233\u201347. https:\/\/doi.org\/10.1056\/NEJMra0910061.","journal-title":"N Engl J Med"},{"key":"354_CR12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00419-2019","volume":"55","author":"VY Lin","year":"2020","unstructured":"Lin VY, Kaza N, Birket SE, et al. Excess mucus viscosity and airway dehydration impact COPD airway clearance. Eur Respir J. 2020;55:1900419. https:\/\/doi.org\/10.1183\/13993003.00419-2019.","journal-title":"Eur Respir J"},{"key":"354_CR13","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(07)61382-8","volume":"370","author":"JA Wedzicha","year":"2007","unstructured":"Wedzicha JA, Seemungal TAR. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370:786\u201396. https:\/\/doi.org\/10.1016\/S0140-6736(07)61382-8.","journal-title":"Lancet"},{"key":"354_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/COPD.S38938","volume":"9","author":"FL Ramos","year":"2014","unstructured":"Ramos FL, Krahnke JS, Kim V. Clinical issues of mucus accumulation in COPD. Int J Chron Obstruct Pulmon Dis. 2014;9:139\u201350. https:\/\/doi.org\/10.2147\/COPD.S38938.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"354_CR15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.2065","author":"AA Diaz","year":"2023","unstructured":"Diaz AA, Orejas JL, Grumley S, et al. Airway-occluding mucus plugs and mortality in patients with chronic obstructive pulmonary disease. JAMA. 2023. https:\/\/doi.org\/10.1001\/jama.2023.2065.","journal-title":"JAMA"},{"key":"354_CR16","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.chest.2023.11.033","volume":"166","author":"SK Mettler","year":"2024","unstructured":"Mettler SK, Nath HP, Grumley S, et al. Silent airway mucus plugs in COPD and clinical implications. Chest. 2024;166:1010\u20139. https:\/\/doi.org\/10.1016\/j.chest.2023.11.033.","journal-title":"Chest"},{"key":"354_CR17","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0086-2016","volume":"26","author":"M McIlwaine","year":"2017","unstructured":"McIlwaine M, Bradley J, Elborn JS, et al. Personalising airway clearance in chronic lung disease. Eur Respir Rev. 2017;26:160086. https:\/\/doi.org\/10.1183\/16000617.0086-2016.","journal-title":"Eur Respir Rev"},{"issue":"8","key":"354_CR18","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009720","volume":"3","author":"BM Button","year":"2013","unstructured":"Button BM, Button B. Structure and function of the mucus clearance of the lung. Cold Spring Harb Perspect Med. 2013;3(8):009720. https:\/\/doi.org\/10.1101\/cshperspect.a009720.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"354_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s41030-021-00178-1","volume":"8","author":"DP Coppolo","year":"2022","unstructured":"Coppolo DP, Schloss J, Suggett JA, Mitchell JP. Non-pharmaceutical techniques for obstructive airway clearance focusing on the role of oscillating positive expiratory pressure (OPEP): a narrative review. Pulm Ther. 2022;8(1):1\u201341. https:\/\/doi.org\/10.1007\/s41030-021-00178-1.","journal-title":"Pulm Ther"},{"issue":"8","key":"354_CR20","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.4187\/respcare.09541058","volume":"54","author":"RD Restrepo","year":"2009","unstructured":"Restrepo RD. A stepwise approach to management of stable COPD with inhaled pharmacotherapy: a review. Respir Care. 2009;54(8):1058\u201381.","journal-title":"Respir Care"},{"key":"354_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s40749-015-0011-0","volume":"1","author":"M Bonini","year":"2015","unstructured":"Bonini M, Usmani OS. The importance of inhaler devices in the treatment of COPD. COPD Res Pract. 2015;1:9. https:\/\/doi.org\/10.1186\/s40749-015-0011-0.","journal-title":"COPD Res Pract"},{"issue":"1","key":"354_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1183\/13993003.00419-2019","volume":"9","author":"R Dhand","year":"2012","unstructured":"Dhand R, Dolovich M, Chipps B, Myers T, Restrepo R, Farrar JR. The role of nebulized therapy in the management of COPD: evidence and recommendations. COPD. 2012;9(1):58\u201372. https:\/\/doi.org\/10.1183\/13993003.00419-2019.","journal-title":"COPD"},{"key":"354_CR23","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.2147\/COPD.S517864","volume":"20","author":"S Sethi","year":"2025","unstructured":"Sethi S, Wan ES, Tejwani V, et al. Burden of exacerbations in patients newly initiating an inhaled regimen for COPD: a claims analysis. Int J Chron Obstruct Pulmon Dis. 2025;20:1829\u201340. https:\/\/doi.org\/10.2147\/COPD.S517864.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"354_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-202598","author":"D Narula","year":"2014","unstructured":"Narula D, Nangia V. Use of an oscillatory PEP device to enhance bronchial hygiene in a patient of post-H1N1 pneumonia and acute respiratory distress syndrome with pneumothorax. BMJ Case Rep. 2014. https:\/\/doi.org\/10.1136\/bcr-2013-202598.","journal-title":"BMJ Case Rep"},{"issue":"Suppl.1","key":"354_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2174\/1874279301206010052","volume":"6","author":"L-MH Wackerhausen","year":"2012","unstructured":"Wackerhausen L-MH, Hansen JG. Risk of infectious diseases in patients with COPD. Open Infect Dis J. 2012;6(Suppl.1):52\u20139. https:\/\/doi.org\/10.2174\/1874279301206010052.","journal-title":"Open Infect Dis J"},{"key":"354_CR26","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1183\/09031936.99.14614189","volume":"14","author":"JA Pryor","year":"1999","unstructured":"Pryor JA. Physiotherapy for airway clearance in adults. Eur Respir J. 1999;14:1418\u201324. https:\/\/doi.org\/10.1183\/09031936.99.14614189.","journal-title":"Eur Respir J"},{"key":"354_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1378\/chest.114.1.171","volume":"114","author":"EM App","year":"1998","unstructured":"App EM, Kieselmann R, Reinhardt D, et al. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy. Chest. 1998;114:171\u20137. https:\/\/doi.org\/10.1378\/chest.114.1.171.","journal-title":"Chest"},{"issue":"Suppl.2","key":"354_CR28","doi-asserted-by":"publisher","first-page":"S177","DOI":"10.1513\/AnnalsATS.201509-641KV","volume":"13","author":"MA Mall","year":"2016","unstructured":"Mall MA. Unplugging mucus in cystic fibrosis and chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2016;13(Suppl.2):S177\u201385. https:\/\/doi.org\/10.1513\/AnnalsATS.201509-641KV.","journal-title":"Ann Am Thorac Soc"},{"key":"354_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9176504","author":"NX Thanh","year":"2019","unstructured":"Thanh NX, Jacobs P, Suggett J, et al. Cost-effectiveness of the Aerobika oscillating positive expiratory pressure device in the management of chronic obstructive pulmonary disease exacerbations in Canada. Can Respir J. 2019. https:\/\/doi.org\/10.1155\/2019\/9176504.","journal-title":"Can Respir J"},{"issue":"8","key":"354_CR30","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1155\/2004\/828591","volume":"11","author":"N Wolkove","year":"2004","unstructured":"Wolkove N, Baltzan A, Kamel H, et al. A randomized trial to evaluate the sustained efficacy of a mucus clearance device in ambulatory patients with chronic obstructive pulmonary disease. Can Respir J. 2004;11(8):567\u201372. https:\/\/doi.org\/10.1155\/2004\/828591.","journal-title":"Can Respir J"},{"issue":"6","key":"354_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3109\/09593981003596616","volume":"26","author":"S Naraparaju","year":"2020","unstructured":"Naraparaju S, Vaishali S, Venkatesan P, et al. Comparison of the Acapella and a threshold inspiratory muscle trainer for sputum clearance in bronchiectasis\u2014a pilot study. Physiother Theory Pract. 2020;26(6):353\u20137. https:\/\/doi.org\/10.3109\/09593981003596616.","journal-title":"Physiother Theory Pract"},{"issue":"2","key":"354_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.17352\/2455-5487.000024","volume":"2","author":"S Jahan","year":"2014","unstructured":"Jahan S, Kumar L, Ahmed F. Comparison of effects of Flutter device versus autogenic drainage on peak expiratory flow rate, oxygen saturation, respiratory rate and pulse rate in COPD patients. J Nov Physiother Phys Rehabil. 2014;2(2):44\u201350. https:\/\/doi.org\/10.17352\/2455-5487.000024.","journal-title":"J Nov Physiother Phys Rehabil"},{"key":"354_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-014-0029-y","volume":"3","author":"S Sethi","year":"2014","unstructured":"Sethi S, Yin J, Anderson PK. Lung flute improves symptoms and health status in COPD with chronic bronchitis: a 26\u00a0week randomized controlled trial. Clin Transl Med. 2014;3:29. https:\/\/doi.org\/10.1186\/s40169-014-0029-y.","journal-title":"Clin Transl Med"},{"issue":"42","key":"354_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001845","volume":"94","author":"AC Gastaldi","year":"2015","unstructured":"Gastaldi AC, Paredi P, Talwar A, et al. Oscillating positive expiratory pressure on respiratory resistance in chronic obstructive pulmonary disease with a small amount of secretion. Medicine (Baltimore). 2015;94(42):e1845. https:\/\/doi.org\/10.1097\/MD.0000000000001845.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"354_CR35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3109\/15412555.2015.1043523","volume":"13","author":"S Svenningsen","year":"2016","unstructured":"Svenningsen S, Paulin GP, Sheikh K, et al. Oscillatory positive expiratory pressure in chronic obstructive pulmonary disease (COPD). COPD. 2016;13(1):66\u201374. https:\/\/doi.org\/10.3109\/15412555.2015.1043523.","journal-title":"COPD"},{"issue":"1","key":"354_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.acra.2016.08.021","volume":"24","author":"S Svenningsen","year":"2017","unstructured":"Svenningsen S, Guo F, McCormack DG, et al. Noncystic fibrosis bronchiectasis: regional abnormalities and response to airway clearance therapy using pulmonary functional magnetic resonance imaging. Acad Radiol. 2017;24(1):4\u201312. https:\/\/doi.org\/10.1016\/j.acra.2016.08.021.","journal-title":"Acad Radiol"},{"issue":"1","key":"354_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s41030-018-0055-9","volume":"4","author":"C Burudpakdee","year":"2018","unstructured":"Burudpakdee C, Seetasith A, Dunne P, et al. A real-world study of 30-day exacerbation outcomes in chronic obstructive pulmonary disease (COPD) patients managed with Aerobika OPEP. Pulm Ther. 2018;4(1):87\u2013101. https:\/\/doi.org\/10.1007\/s41030-018-0055-9.","journal-title":"Pulm Ther"},{"issue":"3","key":"354_CR38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5152\/TurkThoracJ.2018.17050","volume":"19","author":"B \u00dczmezo\u011flu","year":"2018","unstructured":"\u00dczmezo\u011flu B, Altiay G, \u00d6zdemir L, et al. The efficacy of Flutter and active cycle of breathing techniques in patients with bronchiectasis: a prospective, randomized, comparative study. Turk Thorac J. 2018;19(3):103\u20139. https:\/\/doi.org\/10.5152\/TurkThoracJ.2018.17050.","journal-title":"Turk Thorac J"},{"key":"354_CR39","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.2147\/COPD.S213546","volume":"14","author":"S Milan","year":"2019","unstructured":"Milan S, Bondalapati P, Megally M, et al. Positive expiratory pressure therapy with and without oscillation and hospital length of stay for acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2019;14:2553\u201361. https:\/\/doi.org\/10.2147\/COPD.S213546.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"354_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5958\/0973-5674.2019.00014.5","volume":"13","author":"KK Jaiswal","year":"2019","unstructured":"Jaiswal KK, Das AK. Effectiveness of Acapella, Flutter and active cycle of breathing technique on lung function in COPD patients: a comparative study. Ind J Physiother Occ Ther. 2019;13(1):71\u20136. https:\/\/doi.org\/10.5958\/0973-5674.2019.00014.5.","journal-title":"Ind J Physiother Occ Ther"},{"key":"354_CR41","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2147\/COPD.S242191","volume":"15","author":"G Leemans","year":"2020","unstructured":"Leemans G, Belmans D, Holsbeke CV, et al. A functional respiratory imaging approach to the effect of an oscillating positive expiratory pressure device in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2020;15:1261\u20138. https:\/\/doi.org\/10.2147\/COPD.S242191.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"354_CR42","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.2147\/COPD.S256866","volume":"15","author":"J Tse","year":"2020","unstructured":"Tse J, Wada K, Wang Y, et al. Impact of oscillating positive expiratory pressure device use on post-discharge hospitalizations: a retrospective cohort study comparing patients with COPD or chronic bronchitis using the Aerobika and Acapella devices. Int J Chron Obstruct Pulmon Dis. 2020;15:2527\u201338. https:\/\/doi.org\/10.2147\/COPD.S256866.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"354_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-217072","author":"E Daynes","year":"2021","unstructured":"Daynes E, Greening N, Singh SJ. Randomised controlled trial to investigate the use of high-frequency airway oscillations as training to improve dyspnoea (TIDe) in COPD. Thorax. 2021. https:\/\/doi.org\/10.1136\/thoraxjnl-2021-217072.","journal-title":"Thorax"},{"issue":"5","key":"354_CR44","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4103\/lungindia.lungindia_218_22","volume":"39","author":"A Gupta","year":"2022","unstructured":"Gupta A, Sodhi MK, Jaggi S, et al. Therapeutic efficacy of oscillating positive expiratory pressure therapy in stable chronic obstructive pulmonary disease. Lung India. 2022;39(5):449\u201354. https:\/\/doi.org\/10.4103\/lungindia.lungindia_218_22.","journal-title":"Lung India"},{"issue":"5","key":"354_CR45","first-page":"200","volume":"14","author":"S Chandrasekar","year":"2022","unstructured":"Chandrasekar S, Mohamed MA, Laila KV, et al. The efficacy of oscillating positive expiratory pressure (OPEP) therapy in patients with bronchiectasis\u2014a prospective study. Int J Pharm Clin Res. 2022;14(5):200\u20137.","journal-title":"Int J Pharm Clin Res"},{"key":"354_CR46","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1136\/thorax-2022-219077","volume":"78","author":"SM Alghamdi","year":"2022","unstructured":"Alghamdi SM, Barker RE, Alsulayyim ASS, et al. Oscillatory positive expiratory pressure therapy in COPD (O-COPD): a randomised controlled trial. Thorax. 2022;78:136\u201343. https:\/\/doi.org\/10.1136\/thorax-2022-219077.","journal-title":"Thorax"},{"key":"354_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.120238","author":"SN Sahardin","year":"2023","unstructured":"Sahardin SN, Jailaini MFM, Abeed NNN, et al. Impact of Aerobika\u00ae oscillating positive expiratory pressure in improving small airway resistance, lung function, symptoms and exercise capacity in chronic obstructive pulmonary disease. Front Med. 2023. https:\/\/doi.org\/10.3389\/fmed.2023.120238.","journal-title":"Front Med"},{"key":"354_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1159227","author":"SR Kim","year":"2023","unstructured":"Kim SR, Kim S-H, Kim G-H, et al. Effectiveness of the use of an oscillating positive expiratory pressure device in bronchiectasis with frequent exacerbations: a single-arm pilot study. Front Med. 2023. https:\/\/doi.org\/10.3389\/fmed.2023.1159227.","journal-title":"Front Med"},{"key":"354_CR49","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/09031936.00102509","volume":"34","author":"PW Jones","year":"2009","unstructured":"Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34:648\u201354. https:\/\/doi.org\/10.1183\/09031936.00102509.","journal-title":"Eur Respir J"},{"key":"354_CR50","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/thorax.58.4.339","volume":"58","author":"SS Birring","year":"2003","unstructured":"Birring SS, Prudon B, Abeed NNN. Development of a symptom specific health status measure for patients with chronic cough: Leicester cough questionnaire (LCQ). Thorax. 2003;58:339\u201343. https:\/\/doi.org\/10.1136\/thorax.58.4.339.","journal-title":"Thorax"},{"key":"354_CR51","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1053\/rmed.2000.0786","volume":"94","author":"R Garrod","year":"2000","unstructured":"Garrod R, Bestall JC, Paul EA, et al. Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London chest activity of daily living scale (LCADL). Respir Med. 2000;94:589\u201396. https:\/\/doi.org\/10.1053\/rmed.2000.0786.","journal-title":"Respir Med"},{"issue":"6","key":"354_CR52","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370. https:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x.","journal-title":"Acta Psychiatr Scand"},{"key":"354_CR53","doi-asserted-by":"publisher","DOI":"10.1177\/17534666211049743","volume":"15","author":"AM Nguyen","year":"2021","unstructured":"Nguyen AM, Bacci ED, Vernon M, et al. Validation of a visual analog scale for assessing cough severity in patients with chronic cough. Ther Adv Respir Dis. 2021;15:17534666211049743. https:\/\/doi.org\/10.1177\/17534666211049743.","journal-title":"Ther Adv Respir Dis"},{"issue":"1","key":"354_CR54","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/082585979601200102","volume":"12","author":"F Anderson","year":"1996","unstructured":"Anderson F, Downing GM, Hill J. Palliative performance scale (PPS): a new tool. J Palliat Care. 1996;12(1):5\u201311.","journal-title":"J Palliat Care"},{"issue":"1","key":"354_CR55","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1081\/copd-200050513","volume":"2","author":"PW Jones","year":"2005","unstructured":"Jones PW. St George\u2019s respiratory questionnaire: MCID. COPD. 2005;2(1):75\u20139. https:\/\/doi.org\/10.1081\/copd-200050513.","journal-title":"COPD"},{"key":"354_CR56","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2147\/COPD.S38119","volume":"7","author":"J Sundh","year":"2012","unstructured":"Sundh J, Janson C, Lisspers K, et al. Clinical COPD Questionnaire score (CCQ) and mortality. Int J Chron Obstruct Pulmon Dis. 2012;7:833\u201342. https:\/\/doi.org\/10.2147\/COPD.S38119.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"2","key":"354_CR57","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/01823246-200819020-00007","volume":"19","author":"A Chauvin","year":"2008","unstructured":"Chauvin A, Rupley L, Meyers K, et al. Outcomes in cardiopulmonary physical therapy: chronic respiratory disease questionnaire (CRQ). Cardiopulm Phys Ther J. 2008;19(2):61\u20137.","journal-title":"Cardiopulm Phys Ther J"},{"key":"354_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-1-79","author":"K Webster","year":"2003","unstructured":"Webster K, Cella D, Yost K. The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes. 2003. https:\/\/doi.org\/10.1186\/1477-7525-1-79.","journal-title":"Health Qual Life Outcomes"},{"key":"354_CR59","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.rmed.2011.01.007","volume":"105","author":"JM Marin","year":"2011","unstructured":"Marin JM, Cote CG, Diaz O, et al. Prognostic assessment in COPD: health related quality of life and the BODE index. Respir Med. 2011;105:916\u201321. https:\/\/doi.org\/10.1016\/j.rmed.2011.01.007.","journal-title":"Respir Med"},{"key":"354_CR60","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473\u201383.","journal-title":"Med Care"},{"issue":"12","key":"354_CR61","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1164\/rccm.201508-1653OC","volume":"194","author":"B Celli","year":"2016","unstructured":"Celli B, Tetzlaff K, Criner G, et al. COPD biomarker qualification consortium. The 6-minute-walk distance test as a chronic obstructive pulmonary disease stratification tool. Insights from the COPD biomarker qualification consortium. Am J Respir Crit Care Med. 2016;194(12):1483\u201393. https:\/\/doi.org\/10.1164\/rccm.201508-1653OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"354_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2022.106984","volume":"203","author":"A Sunjaya","year":"2022","unstructured":"Sunjaya A, Poulos L, Reddel H, et al. Qualitative validation of the modified Medical Research Council (mMRC) dyspnoea scale as a patient-reported measure of breathlessness severity. Respir Med. 2022;203:106984. https:\/\/doi.org\/10.1016\/j.rmed.2022.106984.","journal-title":"Respir Med"},{"issue":"6","key":"354_CR63","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1378\/chest.107.6.1590","volume":"107","author":"MJ Mador","year":"1995","unstructured":"Mador MJ, Rodis A, Magalang UJ. Reproducibility of Borg scale measurements of dyspnea during exercise in patients with COPD. Chest. 1995;107(6):1590\u20137. https:\/\/doi.org\/10.1378\/chest.107.6.1590.","journal-title":"Chest"},{"key":"354_CR64","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.chest.2019.12.046","volume":"158","author":"Y Okajima","year":"2020","unstructured":"Okajima Y, Come CE, Nardelli P, et al. Luminal plugging on chest CT scan: association with lung function, quality of life, and COPD clinical phenotypes. Chest. 2020;158:121\u201330. https:\/\/doi.org\/10.1016\/j.chest.2019.12.046.","journal-title":"Chest"},{"issue":"6","key":"354_CR65","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/jmri.22375","volume":"32","author":"S Fain","year":"2010","unstructured":"Fain S, Schiebler ML, McCormack DG. Imaging of lung function using hyperpolarized helium-3 magnetic resonance imaging: review of current and emerging translational methods and applications. J Magn Reson Imaging. 2010;32(6):1398\u2013408. https:\/\/doi.org\/10.1002\/jmri.22375.","journal-title":"J Magn Reson Imaging"},{"key":"354_CR66","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v067.i01","author":"D Bates","year":"2015","unstructured":"Bates D, M\u00e4chler M, Bolker BM, et al. Fitting linear mixed-effect models using IME4. J Stat Softw. 2015. https:\/\/doi.org\/10.18637\/jss.v067.i01.","journal-title":"J Stat Softw"},{"issue":"8 Suppl","key":"354_CR67","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.jclinepi.2013.01.013","volume":"66","author":"EA Stuart","year":"2013","unstructured":"Stuart EA, Lee BK, Leacy FP. Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research. J Clin Epidemiol. 2013;66(8 Suppl):S84\u201390. https:\/\/doi.org\/10.1016\/j.jclinepi.2013.01.013.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"354_CR68","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","volume":"189","author":"JD Chalmers","year":"2014","unstructured":"Chalmers JD, Goeminne P, Alberti S, et al. The bronchiectasis severity index: an international derivation and validation study. Am J Respir Crit Care Med. 2014;189(5):576\u201385. https:\/\/doi.org\/10.1164\/rccm.201309-1575OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"354_CR69","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/thorax-2022-219451","volume":"78","author":"A Lewis","year":"2023","unstructured":"Lewis A, Osnadik CR. Changing practice by changing pressures: a role for oscillating positive expiratory pressure in chronic obstructive pulmonary disease. Thorax. 2023;78(2):113\u20135. https:\/\/doi.org\/10.1136\/thorax-2022-219451.","journal-title":"Thorax"},{"key":"354_CR70","unstructured":"National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease in over 16s: diagnosis and management. NICE Guideline [NG115]. 2019; https:\/\/www.nice.org.uk\/guidance\/ng115. Accessed Oct 22, 2025."},{"key":"354_CR71","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1378\/chest.13-1875","volume":"146","author":"S Bickel","year":"2014","unstructured":"Bickel S, Popler J, Lesnick B, et al. Impulse oscillometry: Interpretation and practical applications. Chest. 2014;146:841\u20137. https:\/\/doi.org\/10.1378\/chest.13-1875.","journal-title":"Chest"},{"key":"354_CR72","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1164\/rccm.201711-2202OC","volume":"197","author":"JD Chalmers","year":"2018","unstructured":"Chalmers JD, Aliberti S, Filonenko A, et al. Characterization of the \u201cfrequent exacerbator phenotype\u201d in bronchiectasis. Am J Respir Crit Care Med. 2018;197:1410\u201320. https:\/\/doi.org\/10.1164\/rccm.201711-2202OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"354_CR73","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4046\/trd.2020.0025","volume":"83","author":"HK Kim","year":"2020","unstructured":"Kim HK, Lee H, Kim S-H, et al. Validation of the Korean version of the bronchiectasis health questionnaire. Tuberc Respir Dis. 2020;83:228\u201333. https:\/\/doi.org\/10.4046\/trd.2020.0025.","journal-title":"Tuberc Respir Dis"},{"key":"354_CR74","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01532-2016","volume":"49","author":"A Spinou","year":"2017","unstructured":"Spinou A, Siegert RJ, Guan W-J, et al. The development and validation of the bronchiectasis health questionnaire. Eur Respir J. 2017;49:1601532. https:\/\/doi.org\/10.1183\/13993003.01532-2016.","journal-title":"Eur Respir J"},{"key":"354_CR75","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00687-2024","volume":"63","author":"M Marmor","year":"2024","unstructured":"Marmor M, McShane PJ. Mind the gap: challenges to overcome in airway clearance. Eur Respir J. 2024;63:2400687. https:\/\/doi.org\/10.1183\/13993003.00687-2024.","journal-title":"Eur Respir J"},{"key":"354_CR76","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s41030-018-0055-9","volume":"4","author":"C Burudpakdee","year":"2018","unstructured":"Burudpakdee C, Near AM, Huang H, et al. A real-world evidence study assessing the impact of adding the Aerobika oscillating positive expiratory pressure device to standard of care upon healthcare resource utilization and costs in post-operative patients. Pulm Ther. 2018;4:87\u2013101. https:\/\/doi.org\/10.1007\/s41030-018-0055-9.","journal-title":"Pulm Ther"},{"issue":"20","key":"354_CR77","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1161\/CIRCULATIONAHA.114.010270","volume":"131","author":"CK McIllvennan","year":"2015","unstructured":"McIllvennan CK, Eapen ZJ, Allen LA. Hospital readmissions reduction program. Circulation. 2015;131(20):1796\u2013803. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.010270.","journal-title":"Circulation"},{"key":"354_CR78","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1164\/rccm.202403-0632OC","volume":"211","author":"E Wan","year":"2025","unstructured":"Wan E, Yen AA, Elalami R, et al. Airway mucus plugs on chest computed tomography are associated with exacerbation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2025;211:814\u201322. https:\/\/doi.org\/10.1164\/rccm.202403-0632OC.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Pulmonary Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-026-00354-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41030-026-00354-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-026-00354-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:24:36Z","timestamp":1782141876000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41030-026-00354-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["354"],"URL":"https:\/\/doi.org\/10.1007\/s41030-026-00354-1","relation":{},"ISSN":["2364-1754","2364-1746"],"issn-type":[{"value":"2364-1754","type":"print"},{"value":"2364-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dominic Coppolo and Judy Schloss are employees of Monaghan Medical Corporation (MMC) who market the Aerobika OPEP device in the USA and Mexico; Jason Suggett and Mark Nagel are employees of Trudell Medical International (TMI), manufacturer of both devices and distributor worldwide, except for the USA and Mexico; Jolyon Mitchell is a private consultant who has received funding from TMI and MMC. Jolyon Mitchell is an Editorial Board member of\n                      Pulmonary Therapy\n                      . Jolyon Mitchell was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Breeanna Long is a Respiratory Care Manager in the M Health Fairview system of Hospitals and has received financial support from MMC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The authors have complied with international, national and\/or institutional standards of research reporting in the development of this review article. Its content is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}